Urgent Mental Health Care for Children: NHS Guidance
In light of the growing demand for mental health services, NHS England has released national guidance aimed at improving urgent...
Filter:
Semaglutide and Opioid Overdose Risk in Patients with Type 2 Diabetes and Opioid Use Disorder
The opioid crisis continues to claim thousands of lives each year, with over 107,000 overdose deaths reported in 2023 in...
Antidepressants for Pain Management in Adults with Chronic Pain: A Network Meta-Analysis
Chronic pain affects millions of people worldwide, making everyday activities difficult and significantly reducing quality of life. While antidepressants are...
A New Hope for Metastatic Colorectal Cancer Patients: Trifluridine–Tipiracil and Bevacizumab
For patients with metastatic colorectal cancer, new hope is available through the combination of trifluridine–tipiracil (Lonsurf) and bevacizumab (Avastin), now...
Improving Patient Safety in Primary Care: A New NHS Strategy
Patient safety is a top priority for the NHS, and the new Primary Care Patient Safety Strategy aims to enhance...
Canadian Study Reveals 10 Years of Insights on Clozapine and Antipsychotics: Relapse and Risks
This Canadian study delves into the real-world effectiveness of clozapine compared to other antipsychotics, focusing on relapse rates and adverse...
Digital-First Therapies: Transforming Mental Health Care in the NHS
The NHS is integrating digital therapies to enhance mental health care by offering flexible and accessible treatment options. Discover how...
MHRA Review Finds No Link Between GLP-1 Receptor Agonists and Suicidal Behaviour or Depression
The MHRA has concluded that there is no evidence to support a link between GLP-1 receptor agonists and an increased...
Valproate Use in Men – Risk of Neurodevelopmental Disorders in Offspring
New evidence suggests that valproate use in men may increase the risk of neurodevelopmental disorders in their children, prompting precautionary...
Ocrelizumab Approved as an Injection to Treat Multiple Sclerosis in Adults
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new formulation of ocrelizumab (Ocrevus 920mg solution for injection)...
Stay Safe This Summer: 5 Key Tips for Medicines and Devices
The Medicines and Healthcare products Regulatory Agency (MHRA) provides essential guidance for the safe use of medicines and medical devices...
All Wales Guidance for Penicillin Allergy De-labelling in Adults in Secondary Care
The All Wales Therapeutics and Toxicology Centre (AWTTC) has released comprehensive guidance for de-labelling penicillin allergies in adult patients within...